DK1015446T3 - 4-(Piperidinyl)-1H-2-benzopyranderivater, der er nyttige som antipsykotiske midler - Google Patents
4-(Piperidinyl)-1H-2-benzopyranderivater, der er nyttige som antipsykotiske midlerInfo
- Publication number
- DK1015446T3 DK1015446T3 DK98902628T DK98902628T DK1015446T3 DK 1015446 T3 DK1015446 T3 DK 1015446T3 DK 98902628 T DK98902628 T DK 98902628T DK 98902628 T DK98902628 T DK 98902628T DK 1015446 T3 DK1015446 T3 DK 1015446T3
- Authority
- DK
- Denmark
- Prior art keywords
- piperidinyl
- derivatives useful
- antipsychotic agents
- benzopyran derivatives
- benzopyran
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79710797A | 1997-02-07 | 1997-02-07 | |
| PCT/US1998/000979 WO1998034933A1 (en) | 1997-02-07 | 1998-01-20 | (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1015446T3 true DK1015446T3 (da) | 2003-07-14 |
Family
ID=25169927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98902628T DK1015446T3 (da) | 1997-02-07 | 1998-01-20 | 4-(Piperidinyl)-1H-2-benzopyranderivater, der er nyttige som antipsykotiske midler |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1015446B1 (no) |
| JP (1) | JP4177461B2 (no) |
| KR (1) | KR100509878B1 (no) |
| CN (1) | CN1092653C (no) |
| AR (1) | AR011614A1 (no) |
| AT (1) | ATE236150T1 (no) |
| AU (1) | AU725301B2 (no) |
| BR (1) | BRPI9807312B8 (no) |
| CA (1) | CA2281702C (no) |
| CY (1) | CY2324B1 (no) |
| DE (1) | DE69812980T2 (no) |
| DK (1) | DK1015446T3 (no) |
| ES (1) | ES2194303T3 (no) |
| HK (1) | HK1027812A1 (no) |
| HU (1) | HUP0001308A3 (no) |
| IL (1) | IL131243A (no) |
| NO (1) | NO318936B1 (no) |
| NZ (1) | NZ336719A (no) |
| PT (1) | PT1015446E (no) |
| TW (1) | TW518333B (no) |
| WO (1) | WO1998034933A1 (no) |
| ZA (1) | ZA98831B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1749001T3 (da) * | 2004-04-29 | 2010-06-28 | Aventis Pharma Inc | 3-piperidinylisochroman-5-ol som dopaminagonister |
| PL1748767T3 (pl) | 2004-05-28 | 2012-08-31 | Unigen Inc | 1-(3-metylo-2,4-dimetoksyfenylo)-3-(2',4'-dihydroksyfenylo)-propan jako silny inhibitor tyrozynazy |
| EP2183245B1 (en) | 2007-07-26 | 2014-07-09 | F. Hoffmann-La Roche AG | Dual modulators of 5-ht2a and d3 receptors |
| JP2011528719A (ja) | 2008-07-21 | 2011-11-24 | ユニジェン・インコーポレーテッド | スキンホワイトニング（色を薄くする）化合物系列 |
| US8877778B2 (en) | 2010-12-15 | 2014-11-04 | Hoffmann-La Roche Inc. | Benzofurane compounds |
| CN102079720B (zh) * | 2011-01-20 | 2013-02-06 | 蚌埠丰原医药科技发展有限公司 | 一种制备1-苄基-4-哌啶甲醛的方法 |
| CN109180448A (zh) | 2011-03-24 | 2019-01-11 | 尤尼根公司 | 用于制备二芳基丙烷的化合物和方法 |
| US8921397B2 (en) | 2011-05-04 | 2014-12-30 | Hoffmann-La Roche Inc. | Benzofurane-piperidine compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1552004A (en) * | 1976-05-26 | 1979-09-05 | Takeda Chemical Industries Ltd | Isochroman derivatives |
| US4963568A (en) * | 1989-05-31 | 1990-10-16 | Abbott Laboratories | Dopamine agonists |
-
1998
- 1998-01-20 NZ NZ336719A patent/NZ336719A/xx unknown
- 1998-01-20 AU AU59237/98A patent/AU725301B2/en not_active Expired
- 1998-01-20 WO PCT/US1998/000979 patent/WO1998034933A1/en active IP Right Grant
- 1998-01-20 IL IL13124398A patent/IL131243A/en not_active IP Right Cessation
- 1998-01-20 HU HU0001308A patent/HUP0001308A3/hu unknown
- 1998-01-20 ES ES98902628T patent/ES2194303T3/es not_active Expired - Lifetime
- 1998-01-20 CA CA002281702A patent/CA2281702C/en not_active Expired - Lifetime
- 1998-01-20 EP EP98902628A patent/EP1015446B1/en not_active Expired - Lifetime
- 1998-01-20 KR KR10-1999-7007127A patent/KR100509878B1/ko not_active IP Right Cessation
- 1998-01-20 JP JP53461798A patent/JP4177461B2/ja not_active Expired - Fee Related
- 1998-01-20 DK DK98902628T patent/DK1015446T3/da active
- 1998-01-20 PT PT98902628T patent/PT1015446E/pt unknown
- 1998-01-20 BR BRPI9807312A patent/BRPI9807312B8/pt not_active IP Right Cessation
- 1998-01-20 CN CN98802357A patent/CN1092653C/zh not_active Expired - Lifetime
- 1998-01-20 DE DE69812980T patent/DE69812980T2/de not_active Expired - Lifetime
- 1998-01-20 AT AT98902628T patent/ATE236150T1/de active
- 1998-02-02 ZA ZA98831A patent/ZA98831B/xx unknown
- 1998-02-03 AR ARP980100456A patent/AR011614A1/es active IP Right Grant
- 1998-02-03 TW TW087101327A patent/TW518333B/zh not_active IP Right Cessation
-
1999
- 1999-08-06 NO NO19993812A patent/NO318936B1/no unknown
-
2000
- 2000-11-09 HK HK00107146A patent/HK1027812A1/xx not_active IP Right Cessation
-
2003
- 2003-04-30 CY CY0300037A patent/CY2324B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI9807312B8 (pt) | 2016-09-13 |
| PT1015446E (pt) | 2003-08-29 |
| HUP0001308A3 (en) | 2001-07-30 |
| WO1998034933A1 (en) | 1998-08-13 |
| CN1246859A (zh) | 2000-03-08 |
| JP4177461B2 (ja) | 2008-11-05 |
| CY2324B1 (en) | 2003-11-14 |
| EP1015446B1 (en) | 2003-04-02 |
| DE69812980T2 (de) | 2003-11-13 |
| ZA98831B (en) | 1998-08-07 |
| AR011614A1 (es) | 2000-08-30 |
| AU725301B2 (en) | 2000-10-12 |
| ATE236150T1 (de) | 2003-04-15 |
| KR100509878B1 (ko) | 2005-08-25 |
| TW518333B (en) | 2003-01-21 |
| CN1092653C (zh) | 2002-10-16 |
| KR20000070862A (ko) | 2000-11-25 |
| EP1015446A1 (en) | 2000-07-05 |
| HUP0001308A2 (hu) | 2001-06-28 |
| NO318936B1 (no) | 2005-05-30 |
| BR9807312A (pt) | 2000-05-02 |
| CA2281702A1 (en) | 1998-08-13 |
| JP2001512436A (ja) | 2001-08-21 |
| BR9807312B1 (pt) | 2013-10-29 |
| DE69812980D1 (de) | 2003-05-08 |
| IL131243A (en) | 2004-02-19 |
| ES2194303T3 (es) | 2003-11-16 |
| NO993812D0 (no) | 1999-08-06 |
| AU5923798A (en) | 1998-08-26 |
| NO993812L (no) | 1999-10-05 |
| NZ336719A (en) | 2000-10-27 |
| HK1027812A1 (en) | 2001-01-23 |
| IL131243A0 (en) | 2001-01-28 |
| CA2281702C (en) | 2006-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1175402T3 (da) | Piperidinderivater, der er nyttige som CCR5-antagonister | |
| DK1175401T3 (da) | Piperazinderivater, der er nyttige som CCR5-antagonister | |
| DK1244647T3 (da) | Quinzolinderivater som VIGF-inhibitorer | |
| NO990551D0 (no) | Piperidin- og piperazinderivater, og deres anvendelse som muskarine antagonister | |
| DK1049689T3 (da) | 4-(2-keto-1-benzimidazolinyl)piperidinderivater som ORL1-receptoragonister | |
| DE60019577D1 (de) | 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel | |
| NO20021459D0 (no) | Piperazin-derivater som 5-HT1B-antagonister | |
| NO20012701D0 (no) | Aryl- og heterosyklylsubstituerte pyrimidinderivater som antikoagulanter | |
| NO20023485D0 (no) | 1,3-disubstituerte pyrrolidiner som alfa-2- adrenoceptorantagonister | |
| DK1104420T3 (da) | Substituerede 1,8-naphthyridin-4(1H)-oner som phosphodiesterase-4-inhibitorer | |
| DK1360184T3 (da) | Piperidinderivater som neurokinin-1-antagonister | |
| DK1339685T3 (da) | Biphenylcarboxamider, der er egnede som lipidsænkende midler | |
| NO20021251D0 (no) | Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister | |
| NO20021959D0 (no) | Tetrahydrotiopyranftalazinon-derivater som PDE4-inhibitorer | |
| DK0964863T3 (da) | Oxazolidinoner som 5-HT2A-antagonister | |
| ATE247105T1 (de) | Antipsychotische 4-(1h-indolyl-1-yl)-1- substituierte piperidine derivate | |
| NO20023001D0 (no) | Substituerte piperazinderivater som MTP inhibitorer | |
| DK1231211T3 (da) | Thiazolidindion-derivater som antidiabetika | |
| DK1015446T3 (da) | 4-(Piperidinyl)-1H-2-benzopyranderivater, der er nyttige som antipsykotiske midler | |
| NO20020457D0 (no) | Benzenaminderivater som antikoagulanter | |
| DK1075471T3 (da) | Idolylderivater som serotonerge midler | |
| NO20020485L (no) | Heterocykliske forbindelser som inhiberer angiogenese | |
| ATE315025T1 (de) | Ethansulfonyl-piperidin-derivate | |
| DK1073651T3 (da) | Indolylderivater som serotonerge midler | |
| NO20002575D0 (no) | Substituerte oksimer som neurokininantagonister |